Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02155920
Title Everolimus for Children With Recurrent or Progressive Ependymomaildren With Recurrent or Progressive Ependymoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Texas Southwestern Medical Center
Indications
Therapies
Age Groups: child
Covered Countries USA

Facility Status City State Zip Country Details
Lucile Packard Children's Hospital Stanford University Stanford California 94305 United States Details
New York University Stephen D. Hassenfeld Children's Center for Cancer & Blood Disorders New York New York 10016 United States Details
UT Southwestern Medical Center / Children's Medical Center Dallas Texas 75390 United States Details
Baylor College of Medicine / Texas Children's Hospital Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field